Moving toward a breast cancer vaccine?

New research in mice may be a first step toward a breast cancer vaccine for humans. The findings, published online Sunday and scheduled to run in the June 10 issue of the journal Nature Medicine, found that mice who were genetically engineered to be at high risk for breast cancer were effectively immunized against the disease after being

A breakthrough in vaccine preservation

Vaccines have dramatically impacted global health: by 1979, international vaccination campaigns had successfully led to the eradication of smallpox, which was once estimated to kill as many as 30% of people infected. And since the launch of the World Health Organization’s polio eradication campaign in 1988, widespread vaccination has

For low-income women, hurdles to the HPV vaccine

Low-income women may have too little information about the human papillomavirus (HPV) vaccine to make informed decisions about it, and, due to low rates of follow through with the three-shot series, even those who begin the vaccination process may not be reaping the full protective benefits, according to two studies presented this week

HPV vaccine protection lasts more than 6 years

The human papillomavirus (HPV) vaccine Cervarix, produced by GlaxoSmithKline, offers protection against the two major cancer-causing strains of HPV, (HPV-16 and HPV-18) for more than 6 years, according to research published online today in the British medical journal the Lancet. The analysis, led by Dr. Cosette Wheeler from the

First swine flu vaccines are ready to go

Vaccine producer Baxter International, Inc., says it’s finished its first batch of pandemic H1N1 vaccine and is figuring out distribution plans with the five national health authorities that ordered it.

The U.S. isn’t due to receive any of the 80 million vaccine doses that Baxter will eventually produce this year,

  1. 1
  2. 2
  3. 3
  4. Next